tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Willoughby, 23 are a BUY (58.97%), 14 are a HOLD (35.9%), 2 are a SELL (5.13%).
Analyst Robert Willoughby works at CREDIT SUISSE with a stock forecast success ratio of 53.81% fulfilled within 143.29 days on average.
Robert Willoughby’s has documented 94 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MCK, McKesson at 08-Aug-2022.
Analyst best performing recommendations are on DPLO (DIPLOMAT PHARMACY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 4/28/2017. The price target of $140 was fulfilled within 6 days with a profit of $5.38 (4%) receiving and performance score of 6.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
400
$86.22 (27.48%)
250
7 days ago
27/35 (77.14%)
$98.66 (32.74%)
149
Hold
320
$6.22 (1.98%)
260
10 days ago
7/14 (50%)
$15.26 (5.01%)
146
Buy
355
$41.22 (13.14%)
335
1 months 12 days ago
14/27 (51.85%)
$34.31 (10.70%)
93
Buy
310
$-3.78 (-1.20%)
260
3 months 6 days ago
21/27 (77.78%)
$43.66 (16.39%)
97
Hold
234
$-79.78 (-25.43%)
393
5 months 29 days ago
9/10 (90%)
$43.06 (22.55%)
217
What Year was the first public recommendation made by Robert Willoughby?
